Evofem Biosciences Funding & Investors
San Diego, CA
Evofem Biosciences, Inc. operates as a clinical-stage specialty biopharmaceutical company. The Company focuses on women's medical needs through development and commercialization of women's healthcare products. Evofem Biosciences develops therapeutic solutions to meet sexual and reproductive health needs. Evofem Biosciences serves patients in the United States.
evofem.comTotal Amount Raised: $471,800,000
Evofem Biosciences Funding Rounds
Post Ipo Equity
$1,000,000
Post Ipo Equity Investors
Aditxt TherapeuticsPost Ipo Equity
$26,600,000
Post Ipo Equity
$10,000,000
Post Ipo Equity Investors
Keystone CapitalPost Ipo Equity
$50,000,000
Post Ipo Equity
$30,000,000
Post Ipo Equity Investors
Morgan StanleyStifel Financial Corp.Post Ipo Debt
$25,000,000
Post Ipo Debt Investors
Adjuvant CapitalPost Ipo Equity
$100,000,000
Post Ipo Equity
$50,000,000
Post Ipo Equity Investors
PDL BiopharmaInvescoWoodford Investment ManagementPost Ipo Equity
$30,000,000
Post Ipo Equity Investors
PDL BiopharmaPost Ipo Equity
$36,400,000
Post Ipo Equity
$7,500,000
Post Ipo Equity
$25,000,000
Post Ipo Equity Investors
Woodford Investment ManagementPost Ipo Equity
$20,000,000
Series C
$8,000,000
Series C Investors
Alta PartnersAKS CapitalDomain AssociatesIPO
Unknown
Series C
$6,700,000
Series C Investors
RUSNANOMirae Asset Venture Investment Co.Series C
$20,600,000
Series C Investors
RUSNANOAMOREPACIFIC GroupDomain AssociatesNumoda Capital InnovationsAlta PartnersRMI PartnersSeries Unknown
$25,000,000